CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma

We developed a computational pipeline designed to use RNA sequencing (n = 136) and gene expression profiling (n = 250) data from neuroblastoma tumors to identify cell surface proteins predicted to be highly expressed in MYCN amplified neuroblastomas and with little or no expression in normal human t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sussman, Robyn T., Rokita, Jo Lynne, Huang, Kevin, Raman, Pichai, Rathi, Komal S., Martinez, Daniel, Bosse, Kristopher R., Lane, Maria, Hart, Lori S., Bhatti, Tricia, Pawel, Bruce, Maris, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069022/
https://www.ncbi.nlm.nih.gov/pubmed/32211329
http://dx.doi.org/10.3389/fonc.2020.00302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069022/
https://www.ncbi.nlm.nih.gov/pubmed/32211329
http://dx.doi.org/10.3389/fonc.2020.00302

Ejemplares similares